Related Experiment Video
Updated: Aug 9, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Target genes of the WNT/beta-catenin pathway in Wilms tumors
Birgit Zirn1, Birgit Samans, Stefanie Wittmann
1Physiological Chemistry I, Biozentrum, University of Wuerzburg, Germany.
Abstract:
The WNT/beta-catenin pathway is involved in numerous human cancers. Mutations of the CTNNB1 (beta-catenin) gene have also been detected in a subset of pediatric Wilms tumors, but the target genes of the deregulated WNT/beta-catenin pathway in these tumors have yet to be identified. To compare gene expression profiles of Wilms tumors with and without mutations of CTNNB1, we used 11.5-k cDNA microarrays. Most of the tumors (86%) had received preoperative chemotherapy as mandated by the European SIOP protocol. The comparison between Wilms tumors with and without CTNNB1 mutations revealed several target genes specifically deregulated in CTNNB1-mutated Wilms tumors. Among these, PITX2, APCDD1, and two members of the endothelin axis (EDN3 and EDNRA) are directly activated downstream targets of the WNT/beta-catenin pathway that may enhance proliferation of these tumor cells. In addition, several upstream inhibitors of WNT/beta-catenin signaling like WIF1 and PRDC were also strongly up-regulated in the CTNNB1-mutated Wilms tumors. This overexpression may be a negative feedback mechanism in tumors with uncontrolled WNT signaling. Moreover, we identified deregulated genes in both the retinoic acid and the RAS pathways, such as ATX/ENPP2 and RIS1, suggesting an association between these two pathways with that of WNT. In addition, the strong representation of muscle-related genes in the expression profile of CTNNB1-mutated Wilms tumors corresponded to histologically detectable areas of myomatous cells in these tumors that displayed intense and preferential nuclear beta-catenin antibody staining. This article contains Supplementary Material available at http://www.interscience.wiley.com/jpages/1045-2257/suppmat.
Insights
Pediatric Wilms tumors with CTNNB1 mutations show deregulated WNT/beta-catenin pathway genes, including PITX2 and EDN3, potentially driving tumor growth. Upstream WNT inhibitors are also upregulated, suggesting a feedback loop.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The WNT/beta-catenin pathway is crucial in human cancers.
- CTNNB1 (beta-catenin) gene mutations occur in pediatric Wilms tumors.
- Identifying WNT pathway targets in these tumors is essential.
Purpose of the Study:
- To compare gene expression in Wilms tumors with and without CTNNB1 mutations.
- To identify specific WNT/beta-catenin pathway target genes deregulated in CTNNB1-mutated Wilms tumors.
Main Methods:
- Utilized 11.5-k cDNA microarrays for gene expression profiling.
- Compared tumors with and without CTNNB1 mutations.
- Most tumors (86%) received preoperative chemotherapy per the European SIOP protocol.
Main Results:
- Identified deregulated genes in CTNNB1-mutated Wilms tumors, including PITX2, APCDD1, EDN3, and EDNRA, which are activated WNT/beta-catenin targets.
- Observed upregulation of WNT pathway inhibitors (WIF1, PRDC), suggesting negative feedback.
- Found deregulated retinoic acid and RAS pathway genes (ATX/ENPP2, RIS1), indicating pathway crosstalk.
- Noted enrichment of muscle-related genes correlating with myomatous cell presence and beta-catenin staining.
Conclusions:
- CTNNB1 mutations in Wilms tumors lead to specific WNT/beta-catenin pathway gene deregulation.
- Activated targets like PITX2 and EDN3 may promote tumor proliferation.
- Upregulated inhibitors suggest a feedback mechanism.
- Associations with retinoic acid and RAS pathways warrant further investigation.
More Related Videos
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
